References
- Laberge P, Martineau P. Clarithromycin-induced digoxin intoxication. Ann Pharmacother 1997; 31: 999–1002.
- Morton M, Cooper J. Erythromycin-induced digoxin tox-icity. Ann Pharmacother 1989; 23: 668–670.
- Robertson LW, Chandrasekaran A, Reuning RH, Hui J, Rawal BD. Reduction of digoxin to 20R-dihydrodigoxin by cul-tures of Eubacterium lentum. Appl Environ Microbiol 1986; 51: 1300–1303.
- Saha JR, Butler VP Jr, Neu HC, Lindenbaum J. Digoxin-inactivating bacteria: identification in human gut flora. Science 1983; 220: 325–327.
- Cavet ME, West M, Simmons NL. Transport and epithe-lial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 1996; 118: 1389-1396.
- Fromm M, Kim B, Stein M et al. Inhibition of P-glyco-protein-mediated drug transport, a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 1999; 99: 552–557.
- Newman DJ, Henneberry H, Price CP. Particle-enhanced light scattering immunoassay. Ann Clin Biochem 1992; 29: 22–42.
- Nord CE, Gajjar DA, Grasela DM. Ecological impact on the des-F(6)-quinolone, BMS-284756 on the normal intestinal microflora. Chin Microbiol Infect 2002; 8: 229–239.
- Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1: 101–114.